Health Dictionary Find a Doctor

Stroke

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2] Khizer Yaseen, M.B.B.S.[3]

Synonyms and keywords:

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2] Khizer Yaseen, M.B.B.S.[3]

Overview

Stroke is the rapidly developing loss of brain functions due to a disturbance in the blood vessels supplying blood to the brain. This can be due to ischemia (lack of blood supply) caused by thrombosis or embolism, or due to a hemorrhage. Stroke is a medical emergency and can cause permanent neurological damage, complications and death if not promptly diagnosed and treated. It is the third leading cause of death and the leading cause of adult disability in the United States and Europe. It is predicted that stroke will soon become the leading cause of death worldwide.

.Patent foramen ovale is associated with ischemic stroke of undetermined source, particularly in patients younger than 60 years. Evaluation focuses on determining whether the PFO is causally related to the index stroke and on excluding alternative etiologies.[1]

Historical perspective

The history of stroke goes back to the 5th century B.C. as apoplexy. In 17th century it was discovered that the cause is sudden disruption of blood supply to the brain.

Classification

Ischemic stroke may be classified according to the duration of onset of symptoms and causative agent. The major classification system of ischemic stroke include toast classification system, causative classification of stroke system (CCS),and sparkle classification of ischemic stroke.

Pathophysiology

The pathophysiology of ischemic stroke may depend on the underlying cause of ischemia. Ischemic infarct may be categorized into two types depending on the area of the brain involved as focal ischemic stroke or global ischemic stroke. Hemodynamic changes in ischemic stroke results from cerebral auto regulation dysfunction as brain tissue is highly sensitive to mild changes in oxygen levels. Several minutes of hypoxia leads to irreversible injury. Cerebral auto regulation maintains the perfusion pressure in the brain between the pressure range of 60-150 mm Hg via vasoconstriction and vasodilatation. Prolonged ischemia decreases oxygen delivery to the cells causing anaerobic glycolysis and increased production of free oxygen and nitrate radicals which in turn causes cell membrane, DNA damage and cell death.

Causes

There are several causes for stroke. Some may cause hemorrhage and some causes ischemia. Among all of them there are several lethal causes which we need to be more cautious about them.

Patent foramen ovale may permit paradoxical embolism, allowing venous thrombi to bypass the pulmonary circulation and enter the arterial system, resulting in ischemic stroke.[1]

Differential diagnosis

The differential diagnosis of ischemic stroke may include brain tumour, hemorrhagic stroke, subdural hemorrhage, neurosyphilis, complex or atypical migraine, hypertensive encephalopathy, wernicke’s encephalopathy, CNS abscess, drug toxicity, conversion disorder, electrolyte disturbance, meningitis or encephalitis, multiple sclerosis exacerbation, seizure and hypoglycemia. There are also some conditions which may cause muscle weakness and paralysis such as Botulism, Myasthenia gravis, Guillian-Barre syndrome, Eaton Lambert syndrome, Electrolyte disturbance, Organophosphate toxicity, Multiple sclerosis exacerbation, Amyotrophic lateral sclerosis, Inflammatory myopathy. It is necessary to differentiate these conditions from stroke.

Epidemiology and demographics

The worldwide incident of stroke is about 68 percent and it increases with age. It is more common in men. However, the mortality is more in women. the incident and mortality rates are high in African-American population and developing countries.

Younger patients with ischemic stroke are more likely to have a pathogenic patent foramen ovale, particularly in the absence of traditional vascular risk factors.

Risk Factors

Risk factors for stroke are divided into modifiable and non modifiable risk factors. Modifiable risk factors include hypertension, diabetes mellitus, cardiac disease, cigarette smoking, alcohal consumption, hyperhomocysteinemia, hyperlipidemia, obesity, sedentary life style and oral contraceptive usage. Some of the non modifiable risk factors include advanced age, male gender, family history of ischemic stroke, african-american and hispanic race, and genetic diseases such as sicke cell disease.

Clinical features associated with PFO-related ischemic stroke include younger age, absence of vascular risk factors, and embolic cortical infarction patterns.[2]

Risk Stratifications

The Risk of Paradoxical Embolism (RoPE) score is used to estimate the probability that a detected patent foramen ovale is causally related to ischemic stroke.[2]The PFO-Associated Stroke Causal Likelihood (PASCAL) classification integrates anatomical and clinical features to guide management decisions.[1]

Screening

There are several screening tests for high risk patients to detect and prevent stroke: Carotid Artery Ultrasound, Abdominal Aortic Aneurysm Screening, Atrial Fibrillation, Peripheral Artery Disease.

Natural history, complications and prognosis

Stroke can cause temporary or permanent complications based on the location and time to appropriate treatment. Delayed treatment or sever hemorrhagic or ischemic stroke can lead to death. Other may suffer from Dysphagia, Pneumonia, Myocardial infarction and arrhythmias, need for mechanical ventilation, pulmonary edema, central sleep apnea, urinary incontinence, falls, Musculoskeletal spasticity, Post-stroke seizure, Bowel incontinence, cognitive impairment. Prognosis depends on patient’s age and stroke severity based on clinical evaluation and imaging.

Ischemic stroke due to paradoxical embolism is a recognized complication of patent foramen ovale.[3]Prognosis is influenced by patient age, absence of vascular risk factors, and anatomical characteristics of the PFO.[2]

Diagnosis

Physical Examination

A systematic review found that acute facial paresis, arm drift, or abnormal speech are the best findings.[4]

Electrocardiogram

Electrocardiogram (ECG) may be performed to determine the underlying etiology such as arrhythmias which may result in clots in the heart that may spread to the brain vessels through the bloodstream. Holter monitor may be used to identify intermittent arrhythmias.

Electrocardiography and prolonged rhythm monitoring are mandatory to exclude atrial fibrillation in patients with ischemic stroke of undetermined source..[1]At least 30 days of cardiac rhythm monitoring is recommended.[5]

Echocardiography

Echocardiography may be performed to determine the underlying etiology such as arrhythmias and the resultant clots in the heart that may spread to the brain vessels through the bloodstream.

Echocardiographic evaluation may identify structural cardiac abnormalities associated with embolic stroke mechanisms, including patent foramen ovale.[1] Transesophageal echocardiography with contrast may be used to detect right-to-left shunting. Transesophageal echocardiography allows detection of high-risk PFO features, including large right-to-left shunt, atrial septal aneurysm, long PFO tunnel, and the presence of a Eustachian valve.[6]

Transesophageal echocardiography with contrast and provocative maneuvers is the preferred diagnostic study for identifying patent foramen ovale and for anatomical risk stratification in ischemic stroke. Evaluation should exclude alternative cardioembolic sources.[6]

Transcranial Doppler ultrasonography is a sensitive screening modality for detecting right-to-left shunting but lacks detailed anatomic resolution.[1]

Ultrasound

Ultrasound/doppler study of the carotid arteries can be used to detect carotid stenosis or dissection of the precerebral arteries.

Other Imaging Findings

When a stroke has been diagnosed, various other studies may be performed to determine the underlying etiology. With the current treatment and diagnosis options available, it is of particular importance to determine whether there is a peripheral source of emboli. Test selection may vary, since the cause of stroke varies with age, comorbidity and the clinical presentation. An angiogram of the cerebral vasculature (if a bleed is thought to have originated from an aneurysm or arteriovenous malformation)

MRI FIndings

Magnetic resonance imaging findings of embolic cortical infarcts or infarcts involving multiple vascular territories support a cardioembolic mechanism, including PFO-associated stroke.[7]

Laboratory Findings

Laboratory evaluation is performed to exclude hypercoagulable states and alternative stroke etiologies. Evidence of venous thromboembolism supports paradoxical embolism as a stroke mechanism.[7]

Treatment

Early Assessment

Early recognition of the signs of stroke is generally regarded as important. Only detailed physical examination and medical imaging provide information on the presence, type, and extent of stroke, and hence hospital attendance — even if the symptoms were brief — is advised.

Studies show that patients treated in hospitals with a dedicated Stroke Team or Stroke Unit and a specialized care program for stroke patients have improved odds of recovery.

Medical Therapy

Treatment of stroke is occasionally with thrombolysis (“clot buster”), but usually with supportive care (physiotherapy and occupational therapy) and secondary prevention with antiplatelet drugs (aspirin and often dipyridamole), blood pressure control, statins and anticoagulation (in selected patients).[8]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Saver JL, Mattle HP, Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018 Jun;49(6):1541-1548. doi: 10.1161/STROKEAHA.117.018153. Epub 2018 May 14. PMID: 29760277.
  2. 2.0 2.1 2.2 Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi: 10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17. PMID: 23864310; PMCID: PMC3775694.
  3. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009 Jul;40(7):2349-55. doi: 10.1161/STROKEAHA.109.547828. Epub 2009 May 14. PMID: 19443800; PMCID: PMC2764355.
  4. Goldstein L, Simel D (2005). “Is this patient having a stroke?”. JAMA. 293 (19): 2391–402. doi:10.1001/jama.296.16.2012 url=http://jama.ama-assn.org/cgi/content/full/296/16/2012 Check |doi= value (help). PMID 15900010.
  5. Ospel JM, Kappelhof M, Ganesh A, Kallmes DF, Brinjikji W, Goyal M. Symptomatic non-stenotic carotid disease: current challenges and opportunities for diagnosis and treatment. J Neurointerv Surg. 2024 Mar 14;16(4):418-424. doi: 10.1136/jnis-2022-020005. PMID: 37068939.
  6. 6.0 6.1 Mojadidi MK, Bogush N, Caceres JD, Msaouel P, Tobis JM. Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: a meta-analysis. Echocardiography. 2014 Jul;31(6):752-8. doi: 10.1111/echo.12462. Epub 2013 Dec 23. PMID: 24372693.
  7. 7.0 7.1 Saver JL. Cryptogenic Stroke. N Engl J Med. 2016 Sep 15;375(11):e26. doi: 10.1056/NEJMc1609156. PMID: 27626542.
  8. Hackam DG, Spence JD (2007). “Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study”. Stroke. 38 (6): 1881–5. doi:10.1161/STROKEAHA.106.475525. PMID 17431209.

Template:WS Template:WH

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

The history of stroke goes back to the 5th century B.C. as apoplexy. In 17th century it was discovered that the cause is sudden disruption of blood supply to the brain.

Historical Perspective

Stroke is documented in the Hippocrates notes in the 5th century B.C. as apoplexy, meaning “struck down by violence”, which refers to a person who suddenly falls and becomes unconscious. In 1658, Dr. Johann Jacob Wepfer, pathologist and pharmacologist, discovered that the apoplexy is caused by sudden disruption of blood supply to the brain. He identified that the blood supply to the brain was disrupted either due to bleeding in the brain or blocking of the arteries by blood clots. At this time, physicians also believed that excessive food consumption would cause a person to strain with a bowel movement. This straining was thought to have a possible connection with the occurrence of apoplexy, so purging with enemas and stimulants was used frequently. Exercising and proper body position with the neck and head extension were encouraged to ensure proper blood flow to the brain. Finally, bloodletting had become a common practice, but at this point, restrictions were now being discussed. New guidelines recommended the use of bloodletting judiciously when physicians believed that congestion was the cause of apoplexy in a patient.

Famous Cases

It is believed that actors Luke Perry, Cary Grant and Bill Paxton; actresses Debbie Reynolds, Della Reese and Grace Kelly; former presidents Franklin Roosevelt, Richard Nixon and Gerald Ford; director John Singleton; baseball player Kirby Puckett; former British prime minister Winston Churchill; former Russian dictator Josef Stalin were all the victims of a fatal stroke. In addition, singers Loretta Lynn and Randy Travis; actresses Sharon Stone (“Basic Instinct”) and Marla Gibbs (TV’s “The Jeffersons”); former NFL New England Patriots player Tedy Bruschi; sprinter Michael Johnson; actors Tim Curry (“Rocky Horror Picture Show”) and Frankie Muniz (TV’s “Malcolm In The Middle”); rock singer Bret Michaels have also had the experience of a stroke but have survived.[1][2]

References

  1. Nilsen ML (February 2010). “A historical account of stroke and the evolution of nursing care for stroke patients”. J Neurosci Nurs. 42 (1): 19–27. doi:10.1097/jnn.0b013e3181c1fdad. PMID 20187346.
  2. “Stroke”. The progress-index. 06/28/2022. Check date values in: |date= (help)

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]Seyedmahdi Pahlavani, M.D. [3]Aysha Anwar, M.B.B.S[4],Tarek Nafee, M.D. [5],Sara Mehrsefat, M.D. [6]

Overview

Ischemic stroke may be classified according to the duration of onset of symptoms and causative agent. The major classification system of ischemic stroke include toast classification system, causative classification of stroke system (CCS), and sparkle classification of ischemic stroke.

Classification

Ischemic stroke may be classified according to the duration of onset of symptoms and causative agent. The major classification system of ischemic stroke include: [1][2][3][4][5][6][7]

  • Toast classification system[1]
  • Causative classification of stroke system (CCS)[4]
  • Sparkle classification of ischemic stroke[3]
.
 
 
 
 
 
 
 
 
 
 
 
 
 
Ischemic stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on duration of onset of symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on cause
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transient Ischemic stroke
(symptoms lasts <24 hrs)
 
Acute Ischemic stroke
(symptoms lasts >24 hrs)
 
 
Chronic ischemic stroke
 
 
 
 
 
 
 
Thrombotic
 
 
Embolic[5]

1.Atrial fibrillation
2.Fat
3.Septic
4.Air

5.Cancer
 
 
 
Vasculitic

Giant cell arteritis

Takayasu arteritis
 
 
Systemic hypoperfusion

1.Myocardial infarction
2.Pulmonary embolism
3.Pericardial effusion

4.Bleeding
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TOAST classification[1]

1.Large artery atherosclerosis
2.Cardioembolism
3.Small vessel occlusion
4.Stroke of determined etiology

5.Stroke of undetermined etiology
 
 
 
 
 
 
 
 
 
Arterial thrombosis 1.Carotid artery
2.Vertebral artery
3.Circle of Willis
4.Middle cerbral artery
 
 
 
Venous thrombosis Central venous thrombosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large vessel involvement

1.Atherosclerosis
2.Vasculitis
3.Noninflammatory vasculopathy

4.Fibromuscular dysplasia
 
 
 
 
Small vessel involvement

1.Fibrinoid degeneration
2.Lipohyalinosis

3.Microatheroma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ischemic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemorrhagic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large vessel thromboembolism
 
Cardioembolic
 
Small vessel or Lacunar infarct
 
Intra-axial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extra-axial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intracerebral (ICH)
 
 
Subarachnoid hemorrhage (SAH)
 
 
 
 
 
 
 
Subdural Hemorrhage
 
 
 
 
 
 
 
 
Epidural Hemorrhage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intraparenchymal hemorrhage
 
 
 
 
Intraventricular hemorrhage (IVH)
 
 
 
 
Cerebral microbleeds

References

  1. 1.0 1.1 1.2 Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL; et al. (1993). “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment”. Stroke. 24 (1): 35–41. PMID 7678184.
  2. Adams HP, Biller J (2015). “Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification”. Stroke. 46 (5): e114–7. doi:10.1161/STROKEAHA.114.007773. PMID 25813192.
  3. 3.0 3.1 Bogiatzi C, Wannarong T, McLeod AI, Heisel M, Hackam D, Spence JD (2014). “SPARKLE (Subtypes of Ischaemic Stroke Classification System), incorporating measurement of carotid plaque burden: a new validated tool for the classification of ischemic stroke subtypes”. Neuroepidemiology. 42 (4): 243–51. doi:10.1159/000362417. PMID 24862944.
  4. 4.0 4.1 Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M; et al. (2010). “The Causative Classification of Stroke system: an international reliability and optimization study”. Neurology. 75 (14): 1277–84. doi:10.1212/WNL.0b013e3181f612ce. PMC 3013495. PMID 20921513.
  5. 5.0 5.1 Montanaro VV, da Silva CM, de Viana Santos CV, Lima MI, Negrão EM, de Freitas GR (2016). “Ischemic stroke classification and risk of embolism in patients with Chagas disease”. J Neurol. doi:10.1007/s00415-016-8275-0. PMID 27624118 : 27624118 Check |pmid= value (help).
  6. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ (2005). “An evidence-based causative classification system for acute ischemic stroke”. Ann Neurol. 58 (5): 688–97. doi:10.1002/ana.20617. PMID 16240340.
  7. McArdle PF, Kittner SJ, Ay H, Brown RD, Meschia JF, Rundek T; et al. (2014). “Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study”. Neurology. 83 (18): 1653–60. doi:10.1212/WNL.0000000000000942. PMC 4223086. PMID 25261504.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2],Aysha Anwar, M.B.B.S[3]

Overview

The pathophysiology of ischemic stroke may depend on the underlying cause of ischemia. Ischemic infarct may be categorized into two types depending on the area of the brain involved as focal ischemic stroke or global ischemic stroke. Hemodynamic changes in ischemic stroke results from cerebral auto regulation dysfunction as brain tissue is highly sensitive to mild changes in oxygen levels. Several minutes of hypoxia leads to irreversible injury. Cerebral auto regulation maintains the perfusion pressure in the brain between the pressure range of 60-150 mm Hg via vasoconstriction and vasodilatation. Prolonged ischemia decreases oxygen delivery to the cells causing anaerobic glycolysis and increased production of free oxygen and nitrate radicals which in turn causes cell membrane, DNA damage and cell death.

Pathophysiology

Physiology

The brain receives blood from two sources: the internal carotid arteries, which arise at the point in the neck where the common carotid arteries bifurcate, and the vertebral arteries. The internal carotid arteries branch to form two major cerebral arteries, the anterior and middle cerebral arteries. The right and left vertebral arteries come together at the level of the pons on the ventral surface of the brainstem to form the midline basilar artery. The basilar artery joins the blood supply from the internal carotids in an arterial ring at the base of the brain (in the vicinity of the hypothalamus and cerebral peduncles) called the circle of Willis. The posterior cerebral arteries arise at this confluence, as do two small bridging arteries, the anterior and posterior communicating arteries. Conjoining the two major sources of cerebral vascular supply via the circle of Willis presumably improves the chances of any region of the brain continuing to receive blood if one of the major arteries becomes occluded. The physiological demands served by the blood supply of the brain are particularly significant because neurons are more sensitive to oxygen deprivation than other kinds of cells with lower rates of metabolism. In addition, the brain is at risk from circulating toxins, and is specifically protected in this respect by the blood-brain barrier. As a result of the high metabolic rate of neurons, brain tissue deprived of oxygen and glucose as a result of compromised blood supply is likely to sustain transient or permanent damage. Brief loss of blood supply (referred to as ischemia) can cause cellular changes, which, if not quickly reversed, can lead to cell death. Sustained loss of blood supply leads much more directly to death and degeneration of the deprived cells.

Pathogenesis

The pathogenesis of ischemic stroke may depend on the underlying cause of ischemia. Ischemic infarct may be categorized into two types depending on the area of the brain involved:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][6][8]

Type of ischemia Pathogenesis
Underlying cause Part of the brain involved Time of initiation of cell death Type of cell death
Focal[12]

Thrombosis
Embolism

Focal area supplied by the occluded vessel

Acute onset (3-4 hrs)
Cell death (12 hrs)

Necrosis-central area
Apoptosis- Peripheral area

Global[12]

Systemic hypoperfusion

Water shed area
Hippocampal pyramidal cells, cerebellar purkinjee cells, cortical laminar cells

Delayed onset (12 hrs)
Cell death (days to weeks)

Apoptosis

Traditionally, stroke has been classified into 2 broad categories of stroke syndrome: hemorrhagic (bleeding) stroke and thrombotic (ischemic) stroke. These 2 phenotypes are considered to be diametrically opposite conditions because hemorrhage is characterized by bleeding into the brain tissue resulting in hematoma and brain tissue shift while ischemia is due to thrombosis characterized by “blood clots” within intracranial vasculature leading to hypoxia to a certain part of the brain due to reduced blood supply. Both may result in different clinical brain syndromes even in the same locality.[17][18]

Pathologies affecting large extracranial vessels include:

Pathologies affecting large intracranial vessels include:

Embolic strokes are divided into four categories:

Hemodynamic changes in ischemic stroke

  • Hemodynamic changes in ischemic stroke results from cerebral auto regulation dysfunction as brain tissue is highly sensitive to mild changes in oxygen levels
  • Several minutes of hypoxia leads to irreversible injury[6][8]
  • Cerebral auto regulation maintains the perfusion pressure in the brain between the pressure range of 60-150 mm Hg via vasoconstriction and vasodilatation.[8]
  • Pressure changes below 60 mm Hg and more than 150 mm Hg disrupts the normal auto regulation.
  • Below 60 mm Hg, initially there is extensive vasodilatation of the affected vessels to increase blood flow to the affected area. This is mediated by increase in endothelial nitric oxide production.
  • Extensive increase in nitric oxide production due to sustained hypoxia results in massive vasodialation and formation of large amounts of nitric oxide free radicals causing damage to cellular structures.
  • Drop in blood flow rates below 30ml/100gm results in inhibition of protein synthesis and increase in anaerobic glycolysis
  • Blood flow rates below 20ml/100gm results in extensive membrane damage causing cell death.

Molecular pathophysiology in ischemic stroke

The sequence of molecular changes that may result due to ischemia include:[2][6]

  • Prolonged ischemia- decrease in oxygen delivery to the cells
  • Anaerobic glycolysis with decline in ATP production
  • Increased lactic acid production
  • Increased free oxygen and nitrate radicals-cell membrane and DNA damage[1]
  • Excitatory neurotransmitter –glutamate is increased in neuronal synapses leading to NMDA receptor activation[5][6]
  • NMDA receptor activation causes opening of ion channels in the cell membrane causing K+ efflux and Na+, Ca2+ and water influx
  • Increased Ca2+ influx activates apoptotic cell death pathways
  • ATP required for final steps of apoptosis, hence massive decline in ATP results in necrosis of cells

Cellular changes in Ischemic stroke

The sequence of cellular changes during ischemic stroke results in loss of structural integrity of brain causing disruption of blood brain barrier and cerebral edema.

Genetics

Advances in sequencing technology have facilitated the discovery of single-gene disorders associated with stroke beyond classic syndromes, such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and sickle-cell disease. In addition, heterozygous mutations within the 3ʹ untranslated region of COL4A1 (the gene encoding collagen 4A1) is identified as a cause of pontine autosomal dominant microangiopathy with leukoencephalopathy (PADMAL). Heterozygous mutations (in particular, glycine substitutions) in the triple helical domains of COL4A1 or COL4A2 cause a different syndrome characterized by hemorrhagic stroke along with additional neurological and non-neurological manifestations.[19]

The following gene loci may also increase the risk for stroke:

Gross pathology

  • Central necrotic tissue is called umbra
  • Peripheral tissue which surrounds area of necrosis and can be salvaged with increased blood flow is called pneumbra[4]

Microscopic pathology

  • Within 1-6 min of ischemia, red neurons and vacoulation results [13]
  • If ischemia lasts > 6 min, karryorhexis and cell death occurs

Gross and microscopic changes that may occur due to ischemia with the passage of time is tabulated below: [13][20]

Duration Gross pathology Microscopic pathology[13]
Immediate

<24 hrs

No change Cellular edema
Acute

<1 week

Edema

Loss of grey and white matter junction

Red neurons

Necrosis

Neutrophilia[16]

Subacute

1-4 weeks

Soft friable tissue

Cyst formation

Macrophages

Liquifactive necrosis

Chronic

>4 weeks

Fibrosis

Fluid filled cysts with dark grey margin

Gliosis

Necrotic tissue cleared by macrophages

References

  1. 1.0 1.1 1.2 Rodrigo R, Fernández-Gajardo R, Gutiérrez R, Matamala JM, Carrasco R, Miranda-Merchak A; et al. (2013). “Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities”. CNS Neurol Disord Drug Targets. 12 (5): 698–714. PMID 23469845.
  2. 2.0 2.1 2.2 Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV (2011). “Pathophysiology, treatment, and animal and cellular models of human ischemic stroke”. Mol Neurodegener. 6 (1): 11. doi:10.1186/1750-1326-6-11. PMC 3037909. PMID 21266064.
  3. Pulsinelli W (1992). “Pathophysiology of acute ischaemic stroke”. Lancet. 339 (8792): 533–6. PMID 1346887.
  4. 4.0 4.1 Moustafa RR, Baron JC (2008). “Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery”. Br J Pharmacol. 153 Suppl 1: S44–54. doi:10.1038/sj.bjp.0707530. PMC 2268043. PMID 18037922.
  5. 5.0 5.1 Dirnagl U, Iadecola C, Moskowitz MA (1999). “Pathobiology of ischaemic stroke: an integrated view”. Trends Neurosci. 22 (9): 391–7. PMID 10441299.
  6. 6.0 6.1 6.2 6.3 6.4 Xing C, Arai K, Lo EH, Hommel M (2012). “Pathophysiologic cascades in ischemic stroke”. Int J Stroke. 7 (5): 378–85. doi:10.1111/j.1747-4949.2012.00839.x. PMC 3985770. PMID 22712739.
  7. Deb P, Sharma S, Hassan KM (2010). “Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis”. Pathophysiology. 17 (3): 197–218. doi:10.1016/j.pathophys.2009.12.001. PMID 20074922.
  8. 8.0 8.1 8.2 8.3 del Zoppo GJ, Hallenbeck JM (2000). “Advances in the vascular pathophysiology of ischemic stroke”. Thromb Res. 98 (3): 73–81. PMID 10812160.
  9. Futrell N (1998). “Pathophysiology of acute ischemic stroke: new concepts in cerebral embolism”. Cerebrovasc Dis. 8 Suppl 1: 2–5. PMID 9547024.
  10. Taoufik E, Probert L (2008). “Ischemic neuronal damage”. Curr Pharm Des. 14 (33): 3565–73. PMID 19075733.
  11. Mangubat E, Sani S (2015). “Acute global ischemic stroke after cranioplasty: case report and review of the literature”. Neurologist. 19 (5): 135–9. doi:10.1097/NRL.0000000000000024. PMID 25970836.
  12. 12.0 12.1 12.2 Siesjö BK, Katsura K, Zhao Q, Folbergrová J, Pahlmark K, Siesjö P; et al. (1995). “Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis”. J Neurotrauma. 12 (5): 943–56. PMID 8594224.
  13. 13.0 13.1 13.2 13.3 Mărgăritescu O, Mogoantă L, Pirici I, Pirici D, Cernea D, Mărgăritescu C (2009). “Histopathological changes in acute ischemic stroke”. Rom J Morphol Embryol. 50 (3): 327–39. PMID 19690757 : 19690757 Check |pmid= value (help).
  14. Brinjikji W, Duffy S, Burrows A, Hacke W, Liebeskind D, Majoie CB; et al. (2016). “Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review”. J Neurointerv Surg. doi:10.1136/neurintsurg-2016-012391. PMID 27166383.
  15. Sierra C (2014). “Essential hypertension, cerebral white matter pathology and ischemic stroke”. Curr Med Chem. 21 (19): 2156–64. PMID 24372222.
  16. 16.0 16.1 Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK; et al. (2004). “Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study”. Stroke. 35 (7): 1659–64. doi:10.1161/01.STR.0000130592.71028.92. PMID 15155970.
  17. Chang JC (2020). “Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel “Two-Path Unifying Theory” of Hemostasis”. Clin Appl Thromb Hemost. 26: 1076029620913634. doi:10.1177/1076029620913634. PMC 7427029 Check |pmc= value (help). PMID 32584600 Check |pmid= value (help).
  18. Caplan LR (July 1993). “Brain embolism, revisited”. Neurology. 43 (7): 1281–7. doi:10.1212/wnl.43.7.1281. PMID 8327124.
  19. Dichgans M, Pulit SL, Rosand J (June 2019). “Stroke genetics: discovery, biology, and clinical applications”. Lancet Neurol. 18 (6): 587–599. doi:10.1016/S1474-4422(19)30043-2. PMID 30975520.
  20. Caplan LR (1992). “Intracerebral hemorrhage”. Lancet. 339 (8794): 656–8. PMID 1347346.


Template:WS Template:WH

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2],Seyedmahdi Pahlavani, M.D. [3]Aysha Anwar, M.B.B.S[4],Tarek Nafee, M.D. [5],Sara Mehrsefat, M.D. [6] Khizer Yaseen, M.B.B.S.[7]

Overview

There are several causes for stroke. Some may cause hemorrhage and some causes ischemia. Among all of them there are several lethal causes which we need to be more cautious about them.

Causes

Patent foramen ovale is a potential cause of stroke through paradoxical embolism, in which embolic material from the venous circulation enters the arterial system via a right-to-left intracardiac shunt, resulting in ischemic stroke.[1]

The following table lists causes for stroke.[2][3][4][5][6][7][8][9][10][11]

Causes
Disease Lethal causes Common causes Less common causes
Transient ischemic attack (TIA) Emboli from cardiac source (mostly secondary to AF) Arterial dissection
Ischemic stroke
Intracerebral hemorrhage
Subarachnoid hemorrhage

Rupture of an aneurysm

Rupture of an aneurysm

Subdural hemorrhage Rupture of bridging vessels Trauma (motor vehicle accidents, falls, and assaults)
Epidural hemorrhage Rupture of middle meningeal arteries Trauma (motor vehicle accidents, falls, and assaults)
Intraparenchymal hemorrhage Trauma (motor vehicle accidents, falls, and assaults) Rupture of an aneurysm

Arteriovenous malformation

Intraventricular hemorrhage (IVH)

References

  1. Saver JL, Mattle HP, Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018 Jun;49(6):1541-1548. doi: 10.1161/STROKEAHA.117.018153. Epub 2018 May 14. PMID: 29760277.
  2. Kishimoto M, Arakawa KC (2003). “A patient with wegener granulomatosis and intraventricular hemorrhage”. J Clin Rheumatol. 9 (6): 354–8. doi:10.1097/01.rhu.0000089967.51779.d7. PMID 17043443.
  3. Challa VR, Richards F, Davis CH (1981). “Intraventricular hemorrhage from pituitary apoplexy”. Surg Neurol. 16 (5): 360–1. PMID 7336321.
  4. Flint AC, Roebken A, Singh V (2008). “Primary intraventricular hemorrhage: yield of diagnostic angiography and clinical outcome”. Neurocrit Care. 8 (3): 330–6. doi:10.1007/s12028-008-9070-2. PMID 18320145.
  5. Fukutake T (2011). “Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification”. J Stroke Cerebrovasc Dis. 20 (2): 85–93. doi:10.1016/j.jstrokecerebrovasdis.2010.11.008. PMID 21215656.
  6. Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S; et al. (2012). “SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage”. Stroke. 43 (10): 2592–7. doi:10.1161/STROKEAHA.112.661603. PMID 22858729.
  7. Hart, Robert G., Bradley S. Boop, and David C. Anderson. “Oral anticoagulants and intracranial hemorrhage facts and hypotheses.” Stroke 26.8 (1995): 1471-1477.
  8. Knudsen, Katherine A., et al. “Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.” Neurology 56.4 (2001): 537-539.
  9. Lovelock, C. E., A. J. Molyneux, and P. M. Rothwell. “Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.” The Lancet Neurology 6.6 (2007): 487-493.
  10. Rümke CL (1975). “Letter: Implications of the statement: No side effects were observed”. N Engl J Med. 292 (7): 372–3. PMID 1117973.
  11. Hanley DF (2009). “Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage”. Stroke. 40 (4): 1533–8. doi:10.1161/STROKEAHA.108.535419. PMC 2744212. PMID 19246695.

Template:WH Template:WS

Differentiating Stroke from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2],Aysha Anwar, M.B.B.S[3]

Overview

The differential diagnosis of ischemic stroke may include brain tumor, hemorrhagic stroke, subdural hemorrhage, neurosyphilis, complex or atypical migraine, hypertensive encephalopathy, Wernicke’s encephalopathy, CNS abscess, drug toxicity, conversion disorder, electrolyte disturbance, meningitis or encephalitis, multiple sclerosis exacerbation, seizure and hypoglycemia. There are also some conditions which may cause muscle weakness and paralysis such as Botulism, Myasthenia gravis, Guillian-Barre syndrome, Eaton Lambert syndrome, Electrolyte disturbance, Organophosphate toxicity, Multiple sclerosis exacerbation, Amyotrophic lateral sclerosis, Inflammatory myopathy. It is necessary to differentiate these conditions from stroke.

Differential Diagnosis

Stroke, must be differentiated from other diseases that may cause, altered mental status, motor and or somatosensory deficits. The table below, summarizes the differential diagnosis for stroke:[1][2][3][4][5][4][5][6][7][8][9][10][11]

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
Na+, K+, Ca2+ CT /MRI CSF Findings Gold standard test Motor Deficit Sensory deficit Speech difficulty Gait abnormality Cranial nerves Headache LOC Motor weakness Abnormal sensations
Brain tumour[1] Cancer cells[2] MRI Cachexia, gradual progression of symptoms
Hemorrhagic stroke Xanthochromia[3] CT scan without contrast[4][5] Hypertension Neck stiffness
Subdural hemorrhage CT scan without contrast[4][5] Trauma/fall Confusion, dizziness, nausea, vomiting
Neurosyphilis[6][7] Leukocytes and protein CSF VDRL-specifc

CSF FTA-Ab -sensitive[8]

STIs Blindness, confusion, depression,

Abnormal gait

Complex or atypical migraine Clinical assesment Family history of migraine Presence of aura, nausea, vomiting
Hypertensive encephalopathy Clinical assesment History of hypertension Delirium, cortical blindness, cerebral edema, seizure
Wernicke’s encephalopathy History of alcohal abuse Ophthalmoplegia, confusion
CNS abscess leukocytes, glucose and protien MRI is more sensitive and specific History of drug abuse, endocarditis, immune status High grade fever, fatigue,nausea, vomiting
Drug toxicity Lithium, Sedatives, phenytoin, carbamazepine
Conversion disorder Diagnosis of exclusion Tremors, blindness, difficulty swallowing
Electrolyte disturbance or Depends on the cause Confusion, seizures
Meningitis or encephalitis Leukocytes,

Protein

↓ Glucose

CSF analysis[9] Fever, neck

rigidity

Multiple sclerosis exacerbation CSF IgG levels

(monoclonal bands)

Clinical assesment and MRI [10] History of relapses and remissions Blurry vision, urinary incontinence, fatigue
Seizure ↓ or Clinical assesment and EEG [11] Previous history of seizures Confusion, apathy, irritability,
Hypoglycemia ↓ or Serum blood glucose

HbA1c

History of diabetes Palpitations, sweating, dizziness, low serum, glucose

Stroke should be differentiated from other causes of muscle weakness and paralysis. The differentials include the following:

Diseases History and Physical Diagnostic tests Other Findings
Motor Deficit Sensory deficit Cranial nerve Involvement Autonomic dysfunction Proximal/Distal/Generalized Ascending/Descending/Systemic Unilateral (UL)

or Bilateral (BL)

or

No Lateralization (NL)

Onset Lab or Imaging Findings Specific test
Adult Botulism + + + Generalized Descending BL Sudden Toxin test Blood, Wound, or Stool culture Diplopia, Hyporeflexia, Hypotonia, possible respiratory paralysis
Infant Botulism + + + Generalized Descending BL Sudden Toxin test Blood, Wound, or Stool culture Flaccid paralysis (Floppy baby syndrome), possible respiratory paralysis
Guillian-Barre syndrome[12] + Generalized Ascending BL Insidious CSF: ↑Protein

↓Cells

Clinical & Lumbar Puncture Progressive ascending paralysis following infection, possible respiratory paralysis
Eaton Lambert syndrome[13] + + + Generalized Systemic BL Intermittent EMG, repetitive nerve stimulation test (RNS) Voltage gated calcium channel (VGCC) antibody Diplopia, ptosis, improves with movement (as the day progresses)
Myasthenia gravis[14] + + + Generalized Systemic BL Intermittent EMG, Edrophonium test Ach receptor antibody Diplopia, ptosis, worsening with movement (as the day progresses)
Electrolyte disturbance[15] + + Generalized Systemic BL Insidious Electrolyte panel ↓Ca++, ↓Mg++, ↓K+ Possible arrhythmia
Organophosphate toxicity[16] + + + Generalized Ascending BL Sudden Clinical diagnosis: physical exam & history Clinical suspicion confirmed with RBC AchE activity History of exposure to insecticide or living in farming environment. with : Diarrhea, Urination, Miosis, Bradycardia, Lacrimation, Emesis, Salivation, Sweating
Tick paralysis (Dermacentor tick)[17] + Generalized Ascending BL Insidious Clinical diagnosis: physical exam & history History of outdoor activity in Northeastern United States. The tick is often still latched to the patient at presentation (often in head and neck area)
Tetrodotoxin poisoning[18] + + + Generalized Systemic BL Sudden Clinical diagnosis: physical exam & dietary history History of consumption of puffer fish species.
Stroke[19] +/- +/- +/- +/- Generalized Systemic UL Sudden MRI +ve for ischemia or hemorrhage MRI Sudden unilateral motor and sensory deficit in a patient with a history of atherosclerotic risk factors (diabetes, hypertension, smoking) or atrial fibrillation.
Poliomyelitis[20] + + + +/- Proximal > Distal Systemic BL or UL Sudden PCR of CSF Asymmetric paralysis following a flu-like syndrome.
Transverse myelitis[21] + + + + Proximal > Distal Systemic BL or UL Sudden MRI & Lumbar puncture MRI History of chronic viral or autoimmune disease (e.g. HIV)
Neurosyphilis[6][7] + + +/- Generalized Systemic BL Insidious MRI & Lumbar puncture CSF VDRL-specifc

CSF FTA-Ab -sensitive[8]

History of unprotected sex or multiple sexual partners.

History of genital ulcer (chancre), diffuse maculopapular rash.

Muscular dystrophy[22] + Proximal > Distal Systemic BL Insidious Genetic testing Muscle biopsy Progressive proximal lower limb weakness with calf pseudohypertrophy in early childhood. Gower sign positive.
Multiple sclerosis exacerbation[23] + + + + Generalized Systemic NL Sudden CSF IgG levels

(monoclonal)

Clinical assessment and MRI [10] Blurry vision, urinary incontinence, fatigue
Amyotrophic lateral sclerosis[24] + Generalized Systemic BL Insidious Normal LP (to rule out DDx) MRI & LP Patient initially presents with upper motor neuron deficit (spasticity) followed by lower motor neuron deficit (flaccidity).
Inflammatory myopathy[25] + Proximal > Distal Systemic UL or BL Insidious Elevated CK & Aldolase Muscle biopsy Progressive proximal muscle weakness in 3rd to 5th decade of life. With or without skin manifestations.

References

  1. 1.0 1.1 Morgenstern LB, Frankowski RF (1999). “Brain tumor masquerading as stroke”. J Neurooncol. 44 (1): 47–52. PMID 10582668.
  2. 2.0 2.1 Weston CL, Glantz MJ, Connor JR (2011). “Detection of cancer cells in the cerebrospinal fluid: current methods and future directions”. Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
  3. 3.0 3.1 Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). “Cerebrospinal fluid in cerebral hemorrhage and infarction”. Stroke. 6 (6): 638–41. PMID 1198628.
  4. 4.0 4.1 4.2 4.3 Birenbaum D, Bancroft LW, Felsberg GJ (2011). “Imaging in acute stroke”. West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
  5. 5.0 5.1 5.2 5.3 DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). “ACR Appropriateness Criteria® on cerebrovascular disease”. J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
  6. 6.0 6.1 6.2 Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). “Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients”. J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
  7. 7.0 7.1 7.2 Berger JR, Dean D (2014). “Neurosyphilis”. Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  8. 8.0 8.1 8.2 Ho EL, Marra CM (2012). “Treponemal tests for neurosyphilis–less accurate than what we thought?”. Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.
  9. 9.0 9.1 Carbonnelle E (2009). “[Laboratory diagnosis of bacterial meningitis: usefulness of various tests for the determination of the etiological agent]”. Med Mal Infect. 39 (7–8): 581–605. doi:10.1016/j.medmal.2009.02.017. PMID 19398286.
  10. 10.0 10.1 10.2 Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH; et al. (1994). “Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group”. Arch Neurol. 51 (1): 61–6. PMID 8274111.
  11. 11.0 11.1 Manford M (2001). “Assessment and investigation of possible epileptic seizures”. J Neurol Neurosurg Psychiatry. 70 Suppl 2: II3–8. PMC 1765557. PMID 11385043.
  12. Talukder RK, Sutradhar SR, Rahman KM, Uddin MJ, Akhter H (2011). “Guillian-Barre syndrome”. Mymensingh Med J. 20 (4): 748–56. PMID 22081202.
  13. Merino-Ramírez MÁ, Bolton CF (2016). “Review of the Diagnostic Challenges of Lambert-Eaton Syndrome Revealed Through Three Case Reports”. Can J Neurol Sci. 43 (5): 635–47. doi:10.1017/cjn.2016.268. PMID 27412406.
  14. Gilhus NE (2016). “Myasthenia Gravis”. N Engl J Med. 375 (26): 2570–2581. doi:10.1056/NEJMra1602678. PMID 28029925.
  15. Ozono K (2016). “[Diagnostic criteria for vitamin D-deficient rickets and hypocalcemia-]”. Clin Calcium. 26 (2): 215–22. doi:CliCa1602215222 Check |doi= value (help). PMID 26813501.
  16. Kamanyire R, Karalliedde L (2004). “Organophosphate toxicity and occupational exposure”. Occup Med (Lond). 54 (2): 69–75. PMID 15020723.
  17. Pecina CA (2012). “Tick paralysis”. Semin Neurol. 32 (5): 531–2. doi:10.1055/s-0033-1334474. PMID 23677663.
  18. Bane V, Lehane M, Dikshit M, O’Riordan A, Furey A (2014). “Tetrodotoxin: chemistry, toxicity, source, distribution and detection”. Toxins (Basel). 6 (2): 693–755. doi:10.3390/toxins6020693. PMC 3942760. PMID 24566728.
  19. Kuntzer T, Hirt L, Bogousslavsky J (1996). “[Neuromuscular involvement and cerebrovascular accidents]”. Rev Med Suisse Romande. 116 (8): 605–9. PMID 8848683.
  20. Laffont I, Julia M, Tiffreau V, Yelnik A, Herisson C, Pelissier J (2010). “Aging and sequelae of poliomyelitis”. Ann Phys Rehabil Med. 53 (1): 24–33. doi:10.1016/j.rehab.2009.10.002. PMID 19944665.
  21. West TW (2013). “Transverse myelitis–a review of the presentation, diagnosis, and initial management”. Discov Med. 16 (88): 167–77. PMID 24099672.
  22. Falzarano MS, Scotton C, Passarelli C, Ferlini A (2015). “Duchenne Muscular Dystrophy: From Diagnosis to Therapy”. Molecules. 20 (10): 18168–84. doi:10.3390/molecules201018168. PMID 26457695.
  23. Filippi M, Preziosa P, Rocca MA (2016). “Multiple sclerosis”. Handb Clin Neurol. 135: 399–423. doi:10.1016/B978-0-444-53485-9.00020-9. PMID 27432676.
  24. Riva N, Agosta F, Lunetta C, Filippi M, Quattrini A (2016). “Recent advances in amyotrophic lateral sclerosis”. J Neurol. 263 (6): 1241–54. doi:10.1007/s00415-016-8091-6. PMC 4893385. PMID 27025851.
  25. Michelle EH, Mammen AL (2015). “Myositis Mimics”. Curr Rheumatol Rep. 17 (10): 63. doi:10.1007/s11926-015-0541-0. PMID 26290112.

Template:WikiDoc Sources

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2],Seyedmahdi Pahlavani, M.D. [3]Aysha Anwar, M.B.B.S[4],Tarek Nafee, M.D. [5],Sara Mehrsefat, M.D. [6] Khizer Yaseen, M.B.B.S.[7]

Overview

The worldwide incident of stroke is about 68 percent and it increases with age. It is more common in men. However, the mortality is more in women. the incident and mortality rates are high in African-American population and developing countries.

Epidemiology and Demographics

Incidence

  • Worldwide, the incidence of ischemic stroke is estimated to be 68 percent.[1]
    • Stroke is the third leading cause of death in the Western world, after heart disease and cancer, and causes 10% of deaths worldwide.[2]
  • The incidence of stroke increases exponentially from 30 years of age, and etiology varies by age.[3]

Age

Younger patients with ischemic stroke are more likely to have a pathogenic patent foramen ovale, particularly in the absence of traditional vascular risk factors.[4]

  • Stroke can occur in all age groups. However, the incidence of stroke is less among individuals age less than 40 years of age and the risk increases with increasing age. [5]
  • According to National Health Interview survey data, there is increased number of hospitalizations in patients aged 5-44 years for ischemic stroke.
  • 95% of strokes occur in people age 45 and older; two-thirds of strokes occur in those over the age of 65.[6]
  • A person’s risk of dying if he or she does have a stroke also increases with age.
    • However, stroke can occur at any age, including in fetuses.
  • According to WHO, stroke also occurs in about 8% of children with sickle cell disease. Stroke is the second leading killer of people under 20 years age who suffer from sickle-cell anemia.[7].
  • The incidence of stroke in people aged 18 to 50 years is estimated to be approximately 10%. [8]

Gender

  • Men are 1.25 times more likely to suffer cerebral vascular accidents than women.
    • However, 60% of deaths from stroke occur in women: Since women usually live longer, they are usually older when they suffer from strokes and are more often killed).[6]
  • Some risk factors for stroke apply only to women
    • Primary among these are pregnancy, childbirth, menopause and the treatment thereof (HRT).

Race

  • The risk of incidence of first stroke is twice in African-American population as compared to Caucasians with increased mortality rates.[5]

Geographical distribution

  • There is increased incidence and mortality rates of stroke in developing countries as compared to developed countries due to low socioeconomic status and heath facilities.
  • In the USA, the highest death rates from stroke are in the southeastern United States.[5]

Stroke in USA

  • Stroke is a leading cause of serious long-term disability
  • In USA, the incidence and mortality rates of stroke has significantly decreased compared to previous years.
  • From year 2003 to 2013, the mortality rates due to stroke declined by 18.5%.[8]
  • In 2013, stroke became the fifth leading cause of death.
  • The case fatality rate of stroke is estimated to be 41.7 deaths per 100, 000 population[8]
  • The incidence of new (610, 000) or recurrent stroke (185, 000) is estimated to be 795000 people annually or 250 cases per 100, 000.[8]
  • It is estimated that one incidence of stroke happens every 4 sec with death occurs every 4 min.[8]
  • About 87% of all strokes are ischemic strokes[5]
  • Stroke costs the United States an estimated $34 billion each year[5]

Worldwide

  • According to WHO, the incidence of stroke is estimated to be 15 million people annually, worldwide.[7].
  • Out of these, 5 million die and 5 million are left permanently disabled.[7].

References

  1. Murray CJ, Lopez AD (1997). “Mortality by cause for eight regions of the world: Global Burden of Disease Study”. Lancet. 349 (9061): 1269–76. PMID 9142060.
  2. The World health report 2004. Annex Table 2: Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2002 (PDF). Geneva: World Health Organization. 2004.
  3. Ellekjær, H (1997). “Epidemiology of Stroke in Innherred, Norway, 1994 to 1996 : Incidence and 30-Day Case-Fatality Rate”. Stroke. 28: 2180–2184. PMID 9368561. Retrieved 2008-01-22. Unknown parameter |coauthors= ignored (help)
  4. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi: 10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17. PMID: 23864310; PMCID: PMC3775694.
  5. 5.0 5.1 5.2 5.3 5.4 http://www.cdc.gov/stroke/facts.htm Accessed on November 3, 2016
  6. 6.0 6.1 National Institute of Neurological Disorders and Stroke (NINDS) (1999). “Stroke: Hope Through Research”. National Institutes of Health.
  7. 7.0 7.1 7.2 Mackay, Judith, et al. The atlas of heart disease and stroke. World Health Organization, 2004 Accessed on November 3 2016
  8. 8.0 8.1 8.2 8.3 8.4 Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ; et al. (2016). “Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association”. Circulation. 133 (4): e38–360. doi:10.1161/CIR.0000000000000350. PMID 26673558.


Template:WS Template:WH

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2] Khizer Yaseen, M.B.B.S.[3]

Overview

Risk factors for stroke are divided into modifiable and non-modifiable risk factors. Modifiable risk factors include hypertension, diabetes mellitus, cardiac disease, cigarette smoking, alcohol consumption, hyperhomocysteinemia, hyperlipidemia, obesity, sedentary life style and oral contraceptive usage. Some of the non-modifiable risk factors include advanced age, male gender, family history of ischemic stroke, African-American and Hispanic race, and genetic diseases such as sickle cell disease.

Risk factor

Identification of risk factors for stroke is complicated by the fact that strokes come in many varieties. Risk factors for hemorrhagic and ischemic stroke are similar, but there are some notable differences; there are also differences in risk factors among the etiologic categories of ischemic stroke.[1][2] According to Framingham cohort and later research, the risk factors for ischemic stroke are as follows:

There is a similar classification for the risk factors of hemorrhagic stroke, which is:

  • Modifiable risk factors
  • Non-modifiable risk factors
    • Age
    • Sex
    • Race/Ethnicity

Clinical features associated with PFO-related ischemic stroke include younger age, absence of vascular risk factors, and embolic cortical infarction patterns.[3]

Risk Stratification

The Risk of Paradoxical Embolism (RoPE) score is used to estimate the probability that a detected patent foramen ovale is causally related to ischemic stroke.[4]The PFO-Associated Stroke Causal Likelihood (PASCAL) classification integrates anatomical and clinical features to guide management decisions.[5]

References

  1. Boehme AK, Esenwa C, Elkind MS (February 2017). “Stroke Risk Factors, Genetics, and Prevention”. Circ Res. 120 (3): 472–495. doi:10.1161/CIRCRESAHA.116.308398. PMC 5321635. PMID 28154098.
  2. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S (July 2010). “Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study”. Lancet. 376 (9735): 112–23. doi:10.1016/S0140-6736(10)60834-3. PMID 20561675.
  3. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi: 10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17. PMID: 23864310; PMCID: PMC3775694.
  4. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi: 10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17. PMID: 23864310; PMCID: PMC3775694.
  5. Saver JL, Mattle HP, Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018 Jun;49(6):1541-1548. doi: 10.1161/STROKEAHA.117.018153. Epub 2018 May 14. PMID: 29760277.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

There are several screening tests for high-risk patients to detect and prevent stroke: Carotid Artery Ultrasound, Abdominal Aortic Aneurysm Screening, Atrial Fibrillation, Peripheral Artery Disease.

Screening

It is suggested to use a variety of tests and assessments to detect high-risk patients and prevent stroke events. The tools are as follows:

[1]

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Stroke can cause temporary or permanent complications based on the location and time to appropriate treatment. Delayed treatment or severe hemorrhagic or ischemic stroke can lead to death. Others may suffer from Dysphagia, Pneumonia, Myocardial infarction and arrhythmias, need for mechanical ventilation, pulmonary edema, central sleep apnea, urinary incontinence, falls, Musculoskeletal spasticity, Post-stroke seizure, Bowel incontinence, cognitive impairment. Prognosis depends on patient’s age and stroke severity based on clinical evaluation and imaging.

Natural History

Given the ability to alter the natural history of stroke with endovascular thrombectomy, early identification of patients with vessel occlusion is critical. Differentiating acute ischemic stroke (AIS) patients with large vessel occlusions from those without based on clinical presentation is nonetheless challenging due to the variable nature of collateral vasculature and the potential for unique “at risk” and symptomatic tissue patterning across patients with the same anatomical site of occlusion. Vessel occlusions can also commonly manifest with minimal symptomology. While not pathognomonic, the clinical presentation of patients with vessel occlusion is nonetheless often stereotyped and anatomically matched to the site of occlusion and downstream affected cerebrum. Specifically, ICA or proximal MCA occlusions often present with contralateral hemi body and face weakness and/or numbness, contralateral homonymous hemianopsia, and ipsilateral gaze deviation, as well as aphasia for dominant hemispheric lesions and neglect for lesions of the nondominant hemisphere. More nuanced presentations of variable clinical severity and importance are observed with more distal occlusions. One notable distal occlusion site is the M3 branch to the angular gyrus of the dominant hemisphere. Due to the involvement of this vascular territory in speech processing and complex cognition, focal occlusions in this location are sometimes more aggressively pursued for thrombectomy in an attempt to preserve speech and cognition as compared to similarly distant blockages in arteries supplying less eloquent cortex.[1][2]

Complications

The early complications of patients, survived from a stroke is as follows:[3][4][5]

There are also some long-term complications including:

Prognosis

In the acute phase of stroke, the strongest predictors of outcome are stroke severity and patient age. Stroke severity can be judged clinically, based upon the degree of neurologic impairment (e.g., altered mentation, language, behavior, visual field deficit, motor deficit) and the size and location of the infarction on neuroimaging with magnetic resonance imaging (MRI) or computed tomography (CT). In addition, presence of anemia, atrial fibrillation, cancer, coronary artery disease, dementia, diabetes, heart failure, renal dysfunction, and poor nutrition are among other comorbidities, which can make the prognosis poorer.[6][7][8]


References

  1. Inoue M, Noda R, Yamaguchi S, Tamai Y, Miyahara M, Yanagisawa S, Okamoto K, Hara T, Takeuchi S, Miki K, Nemoto S (April 2018). “Specific Factors to Predict Large-Vessel Occlusion in Acute Stroke Patients”. J Stroke Cerebrovasc Dis. 27 (4): 886–891. doi:10.1016/j.jstrokecerebrovasdis.2017.10.021. PMID 29196201.
  2. Seghier ML (February 2013). “The angular gyrus: multiple functions and multiple subdivisions”. Neuroscientist. 19 (1): 43–61. doi:10.1177/1073858412440596. PMC 4107834. PMID 22547530.
  3. Chohan SA, Venkatesh PK, How CH (December 2019). “Long-term complications of stroke and secondary prevention: an overview for primary care physicians”. Singapore Med J. 60 (12): 616–620. doi:10.11622/smedj.2019158. PMC 7911065 Check |pmc= value (help). PMID 31889205.
  4. Barlas RS, Honney K, Loke YK, McCall SJ, Bettencourt-Silva JH, Clark AB, Bowles KM, Metcalf AK, Mamas MA, Potter JF, Myint PK (August 2016). “Impact of Hemoglobin Levels and Anemia on Mortality in Acute Stroke: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis”. J Am Heart Assoc. 5 (8). doi:10.1161/JAHA.115.003019. PMC 5015269. PMID 27534421.
  5. Coutts SB, Modi J, Patel SK, Aram H, Demchuk AM, Goyal M, Hill MD (November 2012). “What causes disability after transient ischemic attack and minor stroke?: Results from the CT and MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study”. Stroke. 43 (11): 3018–22. doi:10.1161/STROKEAHA.112.665141. PMID 22984013.
  6. Stöllberger C, Exner I, Finsterer J, Slany J, Steger C (2005). “Stroke in diabetic and non-diabetic patients: course and prognostic value of admission serum glucose”. Ann Med. 37 (5): 357–64. doi:10.1080/07853890510037356. PMID 16179271.
  7. Saposnik G, Kapral MK, Liu Y, Hall R, O’Donnell M, Raptis S, Tu JV, Mamdani M, Austin PC (February 2011). “IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke”. Circulation. 123 (7): 739–49. doi:10.1161/CIRCULATIONAHA.110.983353. PMID 21300951.
  8. “Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial”. Stroke. 34 (6): 1450–6. June 2003. doi:10.1161/01.STR.0000074037.49197.8C. PMID 12750536.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH